2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Cardiovascular

31.5 - Does relationship exist between metabolic syndrome and coronary artery calcification in kidney transplant recipients?

Presenter: Andrzej, Adamowicz, Bydgoszcz, Poland
Authors: Adamowicz A., Stróżecki P., Serafin Z., Włodarczyk Z., Manitius J., Lasek W.

DOES RELATIONSHIP EXIST BETWEEN METABOLIC SYNDROME AND CORONARY ARTERY CALCIFICATION IN KIDNEY TRANSPLANT RECIPIENTS?

COMPLICATIONS - CARDIOVASCULAR

A. Adamowicz1, P. Stró?ecki2, Z. Serafin3, Z. W?odarczyk1, J. Manitius2, W. Lasek3
1Dept Of Transplantology And Surgery, Collegium Medicum UMK, Bydgoszcz/POLAND, 2Dept Of Nephrology, Hypertension And Internal Diseases, Collegium Medicum UMK, Bydgoszcz/POLAND, 3Dept Of Radiology And Diagnostic Imaging, Collegium Medicum UMK, Bydgoszcz/POLAND

Body: Introduction: Metabolic syndorme (MS) is a common finding among kidney transplant recipients (KTR). Coronary artery calcification (CAC) is associated with increased mortality in patients with CKD. The relationship was found between MS components and CAC in general population. In recent study in KTR the prevalence of CAC increased with the number of MS components. The aim of our study was to investigate the relationship between MS and CAC in KTR. Patients and methods: The study group consisted of 104 KTR (31 females and 73 males), aged 49±12 years. All patients received graft from deceased donors. Total duration of renal replacement therapy (RRT) was 71±47 months, and kidney transplant follow-up 38±31 months. The diagnosis of MS was based on IDF criteria. CAC was determined with multi-detector row computed tomography as total calcium score (CS) and calcium mass (CM). Systolic and diastolic blood pressure (SBP, DBP) were measured. Fasting blood was sampled for serum lipids, glucose, high-sensitive C-reactive protein (hs-CRP) and serum creatinine. Glomerular filtration rate was calculated with abbreviated MDRD equation (eGFR). Results are expressed as mean±SD Results: Criteria of MS were met in 42 KTR (40%). CAC was found in 72 patients (69%). Patients without MS and patients with MS were compared.

Parameter MS(-) MS(+) P
CAC (+) 40 (65%) 32 (76%) NS
CS 373 ± 614 762 ± 1134 NS
CM (mg) 63 ± 105 127 ± 191 NS
Age 46 ± 12 53 ± 11 0,002
Gender (male) 46(74%) 27(64%) NS
SBP (mmHg) 133 ± 19 135 ± 16 NS
DBP (mmHg) 83 ± 12 82 ± 11 NS
Waist (cm) 84 ± 12 98 ± 10 < 0,001
BMI (kg/m2) 23,8 ± 3,9 27,7 ± 3,7 < 0,001
TG (mg/dl) 135 ± 57 206 ± 91 < 0,001
Cholesterol (mg/dl) 201 ± 38 224 ± 59 < 0,05
LDL-cholesterol (mg/dl) 113 ± 30 121 ± 37 NS
HDL-cholesterol (mg/dl) 61 ± 14 60 ± 17 NS
hs-CRP (mg/l) 2,4 ± 3,2 3,3 ± 3,1 < 0,05
eGFR (ml/min/1,73m2) 58 ± 17 51 ± 17 NS

Significant positive correlation was found between number of MS components and CS (r=0,25; p=0,01) and CM (r=0,26, p=0,007) in the study population. Conclusions: The prevalence of coronary artery calcification in kidney transplant recipients is very high. The presence of coronary artery calcification in kidney transplant recipients is associated with classic risk factors for atherosclerosis but not with metabolic syndrome as a clinical phenomenon.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada